Minerva Neurosciences (NERV)
(Delayed Data from NSDQ)
$3.22 USD
-0.14 (-4.17%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $3.25 +0.03 (0.93%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth D Momentum C VGM
Brokerage Reports
0 items in cart
Minerva Neurosciences, Inc [NERV]
Reports for Purchase
Showing records 41 - 43 ( 43 total )
Company: Minerva Neurosciences, Inc
Industry: Medical - Drugs
Another Win for MIN-202 Differentiates Profile Further
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Minerva Neurosciences, Inc
Industry: Medical - Drugs
Initiating Coverage on Alkermes, Minerva; Assuming Coverage of Trevena
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Minerva Neurosciences, Inc
Industry: Medical - Drugs
A Name for Unmet Needs in Psychiatry; Initiate at Buy With $22 Price Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D